Showing results (71-80 of 122) with videos related to
Sort By:
Pageof 13
Journal of Asthma and Allergy|December 24, 2016
Technical and clinical validation of an environmental exposure unit for ragweedPaul J Gomes, Keith J Lane, Endri Angjeli, et al.Advances in Therapy|May 30, 2003
Multicenter, open-label evaluation of hyperemia associated with use of bimatoprost in adults with open-angle glaucoma or ocular hypertensionMark B Abelson, Michael Mroz, Sarah A Rosner, et al.Clinical Therapeutics|March 5, 2004
Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitisScott M Whitcup, Ron Bradford, John Lue, et al.Advances in Therapy|April 3, 2004
Evaluation of the comfort of Alphagan P compared with Alphagan in irritated eyesThomas Mundorf, Katrina A Wilcox, George W Ousler, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|May 14, 2003
Efficacy of ketotifen fumarate 0.025% ophthalmic solution compared with placebo in the conjunctival allergen challenge modelMark B Abelson, Matthew J Chapin, Barry M Kapik, et al.Cornea|June 4, 2008
The Ocular Protection IndexGeorge W Ousler, Katrina Wilcox Hagberg, Michael Schindelar, et al.Allergy and Asthma Proceedings|December 10, 2008
A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitisLanny J Rosenwasser, Todd Mahr, Mark B Abelson, et al.Clinical Ophthalmology (Auckland, N.Z.)|February 14, 2013
The interblink interval in normal and dry eye subjectsPatrick R Johnston, John Rodriguez, Keith J Lane, et al.Clinical Ophthalmology (Auckland, N.Z.)|February 27, 2013
Investigation of extended blinks and interblink intervals in subjects with and without dry eyeJohn D Rodriguez, George W Ousler, Patrick R Johnston, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 7, 2002
Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: a pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studiesMark B Abelson, Gregg J Berdy, Thomas Mundorf, et al.Pageof 13